Cargando…

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

Despite the genetic inactivation of SMARCA4, a core component of the SWI/SNF-complex commonly found in cancer, there are no therapies that effectively target SMARCA4-deficient tumours. Here, we show that, unlike the cells with activated MYC oncogene, cells with SMARCA4 inactivation are refractory to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero, Octavio A., Vilarrubi, Andrea, Alburquerque-Bejar, Juan J., Gomez, Antonio, Andrades, Alvaro, Trastulli, Deborah, Pros, Eva, Setien, Fernando, Verdura, Sara, Farré, Lourdes, Martín-Tejera, Juan F., Llabata, Paula, Oaknin, Ana, Saigi, Maria, Piulats, Josep M., Matias-Guiu, Xavier, Medina, Pedro P., Vidal, August, Villanueva, Alberto, Sanchez-Cespedes, Montse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280185/ https://www.ncbi.nlm.nih.gov/pubmed/34262032 http://dx.doi.org/10.1038/s41467-021-24618-3

Ejemplares similares

Contingencies of UTX/KDM6A Action in Urothelial Carcinoma
por: Lang, Alexander, et al.
Publicado: (2019)

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
por: Cuyàs, Elisabet, et al.
Publicado: (2018)

UTX/KDM6A Deletion Promotes Recovery of Spinal Cord Injury by Epigenetically Regulating Vascular Regeneration
por: Ni, Shuangfei, et al.
Publicado: (2019)

Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines
por: Lang, Alexander, et al.
Publicado: (2020)

UTX/KDM6A deletion promotes the recovery of spinal cord injury by epigenetically triggering intrinsic neural regeneration
por: Guo, Zhu, et al.
Publicado: (2020)

Epigenetic modifier Kdm6a/Utx controls the specification of hypothalamic neuronal subtypes in a sex-dependent manner
por: Cabrera Zapata, Lucas E., et al.
Publicado: (2022)

Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3
por: Sherry-Lynes, Maureen M., et al.
Publicado: (2017)

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
por: Chang, Soojeong, et al.
Publicado: (2019)

Alternative mRNA Splicing Controls the Functions of the Histone H3K27 Demethylase UTX/KDM6A
por: Fotouhi, Omid, et al.
Publicado: (2023)

UTX/KDM6A suppresses AP-1 and a gliogenesis program during neural differentiation of human pluripotent stem cells
por: Xu, Beisi, et al.
Publicado: (2020)

A KDM6 inhibitor potently induces ATF4 and its target gene expression through HRI activation and by UTX inhibition
por: Kitajima, Shojiro, et al.
Publicado: (2021)

The EP300, KDM5A, KDM6A and KDM6B Chromatin Regulators Cooperate with KLF4 in the Transcriptional Activation of POU5F1
por: Wang, Wan-Ping, et al.
Publicado: (2012)

KDM6 Demethylases and Their Roles in Human Cancers
por: Hua, Chunyan, et al.
Publicado: (2021)

KDM6A and KDM6B play contrasting roles in nuclear transfer embryos revealed by MERVL reporter system
por: Yang, Lei, et al.
Publicado: (2018)

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
por: Walters, Zoë S., et al.
Publicado: (2021)

Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
por: Li, Yunan, et al.
Publicado: (2018)

Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase
por: Lee, Su-Hyun, et al.
Publicado: (2021)

Inhibition of UTX/KDM6A improves recovery of spinal cord injury by attenuating BSCB permeability and macrophage infiltration through the MLCK/p-MLC pathway
por: Xie, Yong, et al.
Publicado: (2023)

Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome
por: Pribadi, Clara, et al.
Publicado: (2020)

KDM6A/B Demethylases in Gut Homeostasis
por: Soshnikova, Natalia
Publicado: (2023)

Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types
por: Sun, Wendi, et al.
Publicado: (2023)

Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019)

KDM6B epigenetically regulates odontogenic differentiation of dental mesenchymal stem cells
por: Xu, Juan, et al.
Publicado: (2013)

The Histone Lysine Demethylase JMJD3/KDM6B Is Recruited to p53 Bound Promoters and Enhancer Elements in a p53 Dependent Manner
por: Williams, Kristine, et al.
Publicado: (2014)

Histone demethylases UTX and JMJD3 are required for NKT cell development in mice
por: Northrup, Daniel, et al.
Publicado: (2017)

The Memory of Environmental Chemical Exposure in C. elegans Is Dependent on the Jumonji Demethylases jmjd-2 and jmjd-3/utx-1
por: Camacho, Jessica, et al.
Publicado: (2018)

A New Isoform of the Histone Demethylase JMJD2A/KDM4A Is Required for Skeletal Muscle Differentiation
por: Verrier, Laure, et al.
Publicado: (2011)

Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells
por: Agger, Karl, et al.
Publicado: (2016)

JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma
por: Macedo-Silva, Catarina, et al.
Publicado: (2020)

Female Bias in Rhox6 and 9 Regulation by the Histone Demethylase KDM6A
por: Berletch, Joel B., et al.
Publicado: (2013)

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
por: Alburquerque-Bejar, Juan J., et al.
Publicado: (2023)

Significance of KDM6A mutation in bladder cancer immune escape
por: Chen, Xingxing, et al.
Publicado: (2021)

JMJD3 and UTX determine fidelity and lineage specification of human neural progenitor cells
por: Shan, Yongli, et al.
Publicado: (2020)

Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed Phenotype
por: Gurrion, Cinthya, et al.
Publicado: (2017)

Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma
por: Arseneault, Madeleine, et al.
Publicado: (2017)

8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors
por: Bavetsias, Vassilios, et al.
Publicado: (2016)

The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability
por: Salifou, Kader, et al.
Publicado: (2016)

Heme promotes transcriptional and demethylase activities of Gis1, a member of the histone demethylase JMJD2/KDM4 family
por: Lal, Sneha, et al.
Publicado: (2018)

Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d
por: Chandwani, Rohit, et al.
Publicado: (2023)

Human histone demethylase KDM6B can catalyse sequential oxidations
por: Hopkinson, Richard J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ck6dun3b8jj2d38hibft8sg4s4